Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER GERALD BUNICK

Allopathic & Osteopathic Physicians Dermatology

NPI
1457527442
CMS profile
718114
Location
NEW HAVEN, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$238,787.03

256 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 256 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER GERALD BUNICK

NPI 1457527442 · CMS profile ID 718114

Allopathic & Osteopathic Physicians / Dermatology

NEW HAVEN, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 256 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1457527442?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER GERALD BUNICK, NPI 1457527442, CMS profile ID 718114. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 256 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1457527442?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). CHRISTOPHER GERALD BUNICK, NPI 1457527442, CMS profile ID 718114. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 256 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1457527442?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
CHRISTOPHER GERALD BUNICK, NPI 1457527442, CMS profile ID 718114, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 256 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1457527442?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

256 matching records · $238,787.03 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 256 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 256.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
UCB, Inc. $65.0008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777668 CMS
UCB, Inc. $125.0008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777670 CMS
UCB, Inc. $130.0008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777672 CMS
UCB, Inc. $130.0008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777674 CMS
UCB, Inc. $329.0008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777676 CMS
UCB, Inc. $368.9708/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777678 CMS
UCB, Inc. $401.4008/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777680 CMS
UCB, Inc. $496.8608/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777682 CMS
UCB, Inc. $1,218.9908/01/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1224777684 CMS
GENZYME CORPORATION $40.8607/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233472234 CMS
E.R. Squibb & Sons, L.L.C. $15.4807/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184866523 CMS
Eli Lilly and Company $43.9407/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186556026 CMS
Eli Lilly and Company $57.4007/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186556602 CMS
Eli Lilly and Company $21.0007/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1186556604 CMS
Eli Lilly and Company $5,600.0007/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186475605 CMS
Eli Lilly and Company $2,800.0007/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1186475607 CMS
LEO Pharma Inc. $3,846.2507/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251995648 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,596.0007/18/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1223774274 CMS
Incyte Corporation $2,250.0007/10/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1225976762 CMS
PFIZER INC. $1,862.5007/08/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1228803622 CMS
ABBVIE INC. $800.0006/26/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1201581581 CMS
Incyte Corporation $17.0006/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226015544 CMS
Incyte Corporation $20.9506/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226144498 CMS
Incyte Corporation $368.5006/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226015522 CMS
Incyte Corporation $386.0006/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226015524 CMS
LEO Pharma Inc. $2,715.0006/18/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251995646 CMS
Incyte Corporation $2,250.0006/17/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1226015436 CMS
PFIZER INC. $131.9406/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230148143 CMS
PFIZER INC. $147.5906/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1231706596 CMS
GENZYME CORPORATION $49.8706/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233472222 CMS
PFIZER INC. $6.8306/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228943215 CMS
Galderma Laboratories, L.P. $1,600.0006/04/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1234623624 CMS
ABBVIE INC. $45.7506/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201581579 CMS
LEO Pharma Inc. $80.9806/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251995644 CMS
ABBVIE INC. $126.7905/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201581577 CMS
Verrica Pharmaceuticals Inc. $53.9505/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222323846 CMS
Galderma Laboratories, L.P. $40.1305/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234623620 CMS
Galderma Laboratories, L.P. $30.7905/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234623622 CMS
LEO Pharma Inc. $42.6005/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251995642 CMS
LEO Pharma Inc. $193.3105/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251995640 CMS
PFIZER INC. $9,320.0005/22/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1228953260 CMS
LEO Pharma Inc. $1,810.0005/20/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251995636 CMS
LEO Pharma Inc. $905.0005/20/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251995638 CMS
GENZYME CORPORATION $5.7905/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233472204 CMS
LEO Pharma Inc. $35.0905/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251995634 CMS
ABBVIE INC. $81.4605/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201581575 CMS
Arcutis Biotherapeutics, Inc. $750.0005/08/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1252334134 CMS
UCB, Inc. $39.5505/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224777664 CMS
LEO Pharma Inc. $3,620.0005/05/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1251995632 CMS
Galderma Laboratories, L.P. $14.8105/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234623618 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $39,005.12 64
PY2020 $16,192.30 15
PY2021 $35,722.86 29
PY2022 $83,467.17 88
PY2023 $92,301.62 106
PY2024 $155,984.27 135
PY2025 $238,787.03 256

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $3,200.00 1
PY2025 Principal investigator $175,207.67 17
PY2024 Recipient $1,270.00 2
PY2024 Principal investigator $255,872.87 49
PY2023 Recipient $1,780.02 5
PY2023 Principal investigator $15,412.92 5
PY2022 Principal investigator $330,607.00 2
PY2020 Principal investigator $236,984.03 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

18 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $8,419.95 12/31/2025 Non-covered Recipient Entity
YALE UNIVERSITY
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202535177
Recipient PFIZER INC. $3,200.00 12/22/2025 Covered Recipient Physician ABROCITINIB CLINICAL PUBLICATION PROGRAM No dispute reported 06/30/2026 1228726820
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $39,671.38 12/12/2025 Non-covered Recipient Entity
YALE UNIVERSITY
TAK-279-PsO-3004 A Phase 3, multi-center, head to head Study To Evaluate The Efficacy, Safety, And Tolerability of TAK-279 in Subjects With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1223289692
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $4,847.12 12/12/2025 Non-covered Recipient Entity
YALE UNIVERSITY
TAK-279-PsO-3004 A Phase 3, multi-center, head to head Study To Evaluate The Efficacy, Safety, And Tolerability of TAK-279 in Subjects With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1223289694
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $276.97 12/01/2025 Non-covered Recipient Entity
YALE UNIVERSITY
TAK-279-PsO-3004 A Phase 3, multi-center, head to head Study To Evaluate The Efficacy, Safety, And Tolerability of TAK-279 in Subjects With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1223288983
Principal investigator 1 Daiichi Sankyo Company LTD $25,571.00 11/07/2025 Non-covered Recipient Entity
Yale University
DS7011-107 No dispute reported 06/30/2026 1186252581
Principal investigator 1 Daiichi Sankyo Inc. $25,571.00 11/07/2025 Covered Recipient Teaching Hospital
Dana-Farber Cancer Institute
DS7011-107 No dispute reported 06/30/2026 1223367187
Principal investigator 1 ABBVIE INC. $5,568.75 10/17/2025 Non-covered Recipient Entity
YALE UNIVERSITY
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202517431
Principal investigator 1 Daiichi Sankyo Company LTD $4,991.00 10/03/2025 Non-covered Recipient Entity
Yale University
DS7011-107 No dispute reported 06/30/2026 1186252577
Principal investigator 1 Daiichi Sankyo Inc. $506.00 10/03/2025 Covered Recipient Teaching Hospital
Dana-Farber Cancer Institute
DS7011-107 No dispute reported 06/30/2026 1223367181
Principal investigator 1 Daiichi Sankyo Inc. $3,055.00 10/03/2025 Covered Recipient Teaching Hospital
Dana-Farber Cancer Institute
DS7011-107 No dispute reported 06/30/2026 1223367183
Principal investigator 1 Daiichi Sankyo Inc. $1,430.00 10/03/2025 Covered Recipient Teaching Hospital
Dana-Farber Cancer Institute
DS7011-107 No dispute reported 06/30/2026 1223367185
Principal investigator 1 ABBVIE INC. $1,800.00 08/21/2025 Non-covered Recipient Entity
YALE UNIVERSITY
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202505485
Principal investigator 1 ABBVIE INC. $3,250.00 07/24/2025 Non-covered Recipient Entity
YALE UNIVERSITY
A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (Level Up) No dispute reported 06/30/2026 1202499616
Principal investigator 1 Daiichi Sankyo Company LTD $930.00 07/16/2025 Non-covered Recipient Entity
Yale University
DS7011-107 No dispute reported 06/30/2026 1186252579
Principal investigator 1 Daiichi Sankyo Inc. $930.00 07/16/2025 Covered Recipient Teaching Hospital
Dana-Farber Cancer Institute
DS7011-107 No dispute reported 06/30/2026 1223367179
Principal investigator 1 ABBVIE INC. $36,234.50 06/03/2025 Non-covered Recipient Entity
YALE UNIVERSITY
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab (Switch-Up) No dispute reported 06/30/2026 1202487695
Principal investigator 1 Eli Lilly and Company $12,155.00 01/07/2025 Non-covered Recipient Entity
YALE UNIVERSITY
AN OPEN-LABEL, 24-WEEK STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AND SKIN OF COLOR No dispute reported 06/30/2026 1187891388